Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules
Abstract Background The high false‐positive rate for pulmonary nodules (PNs) from using low‐dose computed tomography (LDCT) screening can lead to overuse of invasive procedures, overtreatment, and patient anxiety. Therefore, it is very important to develop new diagnostic methods. Methods A negative...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-12-01
|
| Series: | Thoracic Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/1759-7714.14702 |
| _version_ | 1797987413591588864 |
|---|---|
| author | Guojun Ma Dawei Yang Yang Li Meng Li Jingtao Li Jianhua Fu Zhongmin Peng |
| author_facet | Guojun Ma Dawei Yang Yang Li Meng Li Jingtao Li Jianhua Fu Zhongmin Peng |
| author_sort | Guojun Ma |
| collection | DOAJ |
| description | Abstract Background The high false‐positive rate for pulmonary nodules (PNs) from using low‐dose computed tomography (LDCT) screening can lead to overuse of invasive procedures, overtreatment, and patient anxiety. Therefore, it is very important to develop new diagnostic methods. Methods A negative enrichment‐fluorescence in situ hybridization (NE‐FISH) approach was used to detect circulating tumor cells (CTCs) in patients with PNs. We evaluated whether or not the combination of CTC counts with serum tumor marker levels (CEA, CA 125, CYFRA 21‐1, SCC) could improve the diagnostic ability for distinguishing patients with malignant pulmonary nodules (MPNs) from those with benign pulmonary nodules (BPNs). Moreover, the potential clinical application of this combination for the diagnosis of solitary pulmonary nodules (SPNs) with a diameter ≤2 cm was also investigated. Results The combination of CTC counts and tumor marker levels had a sensitivity of 80.12% and the area under the receiver operating characteristics curve (AUCROC) of 0.853 (95% confidence interval [CI]: 0.800–0.897, p < 0.001) for the differential diagnosis of PNs. For early cancer stages, the sensitivity was 75.38% (AUCROC = 0.780, 95% CI: 0.713–0.838, p < 0.001). In addition, for SPNs within 2 cm the combination of CTC counts and tumor marker levels was still the most valuable diagnostic tool with a sensitivity of 78.95% and AUCROC of 0.888. Conclusion The combination of CTC counts and serum tumor marker levels is helpful for improving the diagnosis of PNs, especially in the early stages of cancer and for SPNs within 2 cm. |
| first_indexed | 2024-04-11T07:48:18Z |
| format | Article |
| id | doaj.art-66e3f277c66740f79f8befd3be9c6644 |
| institution | Directory Open Access Journal |
| issn | 1759-7706 1759-7714 |
| language | English |
| last_indexed | 2024-04-11T07:48:18Z |
| publishDate | 2022-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | Thoracic Cancer |
| spelling | doaj.art-66e3f277c66740f79f8befd3be9c66442022-12-22T04:36:11ZengWileyThoracic Cancer1759-77061759-77142022-12-0113233393340110.1111/1759-7714.14702Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodulesGuojun Ma0Dawei Yang1Yang Li2Meng Li3Jingtao Li4Jianhua Fu5Zhongmin Peng6Department of Thoracic Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine Shandong University Jinan ChinaZhong Yuan Academy of Biological Medicine Liaocheng People's Hospital Liaocheng ChinaZhong Yuan Academy of Biological Medicine Liaocheng People's Hospital Liaocheng ChinaDepartment of Thoracic Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine Shandong University Jinan ChinaDepartment of Thoracic Surgery Liaocheng People's Hospital Liaocheng ChinaDepartment of Thoracic Surgery Liaocheng People's Hospital Liaocheng ChinaDepartment of Thoracic Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine Shandong University Jinan ChinaAbstract Background The high false‐positive rate for pulmonary nodules (PNs) from using low‐dose computed tomography (LDCT) screening can lead to overuse of invasive procedures, overtreatment, and patient anxiety. Therefore, it is very important to develop new diagnostic methods. Methods A negative enrichment‐fluorescence in situ hybridization (NE‐FISH) approach was used to detect circulating tumor cells (CTCs) in patients with PNs. We evaluated whether or not the combination of CTC counts with serum tumor marker levels (CEA, CA 125, CYFRA 21‐1, SCC) could improve the diagnostic ability for distinguishing patients with malignant pulmonary nodules (MPNs) from those with benign pulmonary nodules (BPNs). Moreover, the potential clinical application of this combination for the diagnosis of solitary pulmonary nodules (SPNs) with a diameter ≤2 cm was also investigated. Results The combination of CTC counts and tumor marker levels had a sensitivity of 80.12% and the area under the receiver operating characteristics curve (AUCROC) of 0.853 (95% confidence interval [CI]: 0.800–0.897, p < 0.001) for the differential diagnosis of PNs. For early cancer stages, the sensitivity was 75.38% (AUCROC = 0.780, 95% CI: 0.713–0.838, p < 0.001). In addition, for SPNs within 2 cm the combination of CTC counts and tumor marker levels was still the most valuable diagnostic tool with a sensitivity of 78.95% and AUCROC of 0.888. Conclusion The combination of CTC counts and serum tumor marker levels is helpful for improving the diagnosis of PNs, especially in the early stages of cancer and for SPNs within 2 cm.https://doi.org/10.1111/1759-7714.14702circulating tumor cellsdiagnosisearly stagespulmonary nodulestumor markers |
| spellingShingle | Guojun Ma Dawei Yang Yang Li Meng Li Jingtao Li Jianhua Fu Zhongmin Peng Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules Thoracic Cancer circulating tumor cells diagnosis early stages pulmonary nodules tumor markers |
| title | Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules |
| title_full | Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules |
| title_fullStr | Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules |
| title_full_unstemmed | Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules |
| title_short | Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules |
| title_sort | combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules |
| topic | circulating tumor cells diagnosis early stages pulmonary nodules tumor markers |
| url | https://doi.org/10.1111/1759-7714.14702 |
| work_keys_str_mv | AT guojunma combinedmeasurementofcirculatingtumorcellcountsandserumtumormarkerlevelsenhancesthescreeningefficiencyformalignantversusbenignpulmonarynodules AT daweiyang combinedmeasurementofcirculatingtumorcellcountsandserumtumormarkerlevelsenhancesthescreeningefficiencyformalignantversusbenignpulmonarynodules AT yangli combinedmeasurementofcirculatingtumorcellcountsandserumtumormarkerlevelsenhancesthescreeningefficiencyformalignantversusbenignpulmonarynodules AT mengli combinedmeasurementofcirculatingtumorcellcountsandserumtumormarkerlevelsenhancesthescreeningefficiencyformalignantversusbenignpulmonarynodules AT jingtaoli combinedmeasurementofcirculatingtumorcellcountsandserumtumormarkerlevelsenhancesthescreeningefficiencyformalignantversusbenignpulmonarynodules AT jianhuafu combinedmeasurementofcirculatingtumorcellcountsandserumtumormarkerlevelsenhancesthescreeningefficiencyformalignantversusbenignpulmonarynodules AT zhongminpeng combinedmeasurementofcirculatingtumorcellcountsandserumtumormarkerlevelsenhancesthescreeningefficiencyformalignantversusbenignpulmonarynodules |